Literature DB >> 12376918

Demyelinating pseudotumor.

Irma E Erana-Rojas1, Alvaro Barboza-Quintana, Alberto G Ayala, Gregory N Fuller.   

Abstract

Demyelinating disease presenting as a solitary contrast-enhancing mass poses a diagnostic challenge for both radiologists and surgical pathologists. We report the cases of two female patients, aged 23 and 37 years, who exhibited the clinical and radiologic features of a space-occupying mass strongly suggestive of neoplasia. In both patients, magnetic resonance imaging showed a ring-enhancing parietal lesion. Intraoperative frozen sections in both patients displayed histologic features strongly suggestive of a glial neoplasm, including marked hypercellularity, a prominent astrocytic component, and easily identifiable mitotic figures. However, permanent sections showed additional and helpful histologic findings that included Creutzfeldt astrocytes and granular mitoses. Subsequent immunostaining showed that the hypercellularity was principally caused by macrophage infiltration (HAM-56 and CD68) and an associated reactive astrocytosis (glial fibrillary acidic protein). Additional confirmatory tests included special stains for myelin (Luxol-fast-blue), which demonstrated focal, sharply marginated loss of myelin, and for axons (silver stain for axons and neurofilament protein immunohistochemistry), which showed relative preservation of axons in areas of myelin loss. Together, the special stains confirmed the demyelinating nature of the lesions. The keys to avoiding misdiagnosing a demyelinating pseudotumor as a diffuse glioma include a general awareness of this potential pitfall, including the radiologic appearance of demyelinating pseudotumors as contrast-enhancing solitary masses that mimic tumor; knowledge of the characteristic histologic features, including Creutzfeldt astrocytes and granular mitoses; and a high index of suspicion for macrophage infiltration combined with a willingness to use appropriate confirmatory immunohistochemical studies in suspicious or uncertain cases. This approach will minimize the chance of misdiagnosis and subsequent use of inappropriate and deleterious therapies. Copyright 2002, Elsevier Science (USA)

Entities:  

Mesh:

Year:  2002        PMID: 12376918     DOI: 10.1053/adpa.2002.35737

Source DB:  PubMed          Journal:  Ann Diagn Pathol        ISSN: 1092-9134            Impact factor:   2.090


  6 in total

Review 1.  Tumefactive demyelinating lesions: nine cases and a review of the literature.

Authors:  Lei Xia; Song Lin; Zhong-cheng Wang; Shao-wu Li; Li Xu; Jing Wu; Shu-yu Hao; Chuan-chuan Gao
Journal:  Neurosurg Rev       Date:  2009-01-27       Impact factor: 3.042

Review 2.  Astrocytes: biology and pathology.

Authors:  Michael V Sofroniew; Harry V Vinters
Journal:  Acta Neuropathol       Date:  2009-12-10       Impact factor: 17.088

3.  Creutzfeldt astrocytes may be seen in IDH-wildtype glioblastoma and retain expression of DNA repair and chromatin binding proteins.

Authors:  Leomar Y Ballester; Zain Boghani; David S Baskin; Gavin W Britz; Randall Olsen; Gregory N Fuller; Suzanne Z Powell; Matthew D Cykowski
Journal:  Brain Pathol       Date:  2018-04-25       Impact factor: 7.611

4.  Creutzfeldt Cell Rich Glioblastoma: A Diagnostic Dilemma.

Authors:  Zain Boghani; William J Steele; Matthew D Cykowski; Leomar Y Ballester; Gavin Britz
Journal:  Cureus       Date:  2017-10-05

5.  Integrative and comparative single-cell analysis reveals transcriptomic difference between human tumefactive demyelinating lesion and glioma.

Authors:  Xiao-Yong Chen; Yue Chen; Wen-Hua Fang; Zan-Yi Wu; Deng-Liang Wang; Ya-Wen Xu; Liang-Hong Yu; Yuan-Xiang Lin; De-Zhi Kang; Chen-Yu Ding
Journal:  Commun Biol       Date:  2022-09-09

6.  Imaging and clinical properties of inflammatory demyelinating pseudotumor in the spinal cord.

Authors:  Ying Wang; Min Wang; Hui Liang; Quntao Yu; Zhihui Yan; Min Kong
Journal:  Neural Regen Res       Date:  2013-09-15       Impact factor: 5.135

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.